Corporate

  • December 19, 2025

    Taxation With Representation: Baker Botts, Morgan Lewis

    In this week's Taxation With Representation, Trump Media and Technology Group merges with fusion power company TAE Technologies, pharmaceutical company Cencora boosts its stake in cancer care company OneOncology, and Phoenix Financial partners with private equity giant Blackstone to plug billions into various credit strategies.

  • December 19, 2025

    3 Firms Advise As Sony Nabs Majority Stake In Peanuts Brand

    WildBrain has agreed to sell its 41% stake in Peanuts Holdings LLC to Sony Music Entertainment (Japan) Inc. and Sony Pictures Entertainment Inc. for C$630 million in cash, or roughly $457 million, in a deal steered by three law firms. 

  • December 19, 2025

    J&J, ChemImage Reach Deal After $77M AI Patent Judgment

    Johnson & Johnson has entered an agreement to resolve a lawsuit that ChemImage Corp. had brought alleging the pharmaceutical giant unilaterally ended a deal to develop in-surgery artificial intelligence imaging techniques, after a New York federal judge determined J&J owed $76.6 million in the dispute.

  • December 19, 2025

    If GCs Can't Do It, How Do We Hold Boeing Accountable?

    Several years ago, Ben Heineman Jr. — often referred to as the father of modern-day general counsel — spoke with me about his view of a general counsel's role in shaping a company's corporate culture and ethics.

  • December 19, 2025

    Chancery Keeps Alive Electric Vehicle Co. SPAC Suit

    Most counts have gone forward in a Delaware Court of Chancery suit alleging an unfair "blank check" company take-public merger with a since-reorganized electric vehicle company that faced allegedly undisclosed supply chain problems.

  • December 19, 2025

    BioMarin Inks $4.8B Amicus Buy As Patent Litigation Resolved

    BioMarin Pharmaceutical Inc. has agreed to acquire Amicus Therapeutics for $4.8 billion, in a deal bolstered by Amicus' settlement of patent litigation that secures U.S. exclusivity for its Galafold drug until 2037, the companies said Friday.

  • December 19, 2025

    NLRB To Get Quorum, GC As Senate Confirms Trump Picks

    The National Labor Relations Board is set to end 2025 with a quorum after the U.S. Senate confirmed the president's nominees to two board vacancies and the agency's open general counsel post as part of a bloc of picks for jobs across the government.

  • December 18, 2025

    The Biggest Rulings From A Busy Year At The 1st Circ.

    The nation's smallest federal appellate panel punched above its weight in 2025, grappling with numerous suits against the Trump administration, high-profile criminal appeals, a $34 million legal fee bid and a hotly contested kickback law.

  • December 18, 2025

    OCC Ends Citi Risk Management Resource Review Order

    The Office of the Comptroller of the Currency on Thursday formally ended a 2024 amendment to a previous consent order against Citibank over its risk management practices, with Citibank saying the relevant remediation programs are "nearly at target-state."

  • December 18, 2025

    Feds Say PE Firm Founder Funded Wife's Co. With $50M Fraud

    The managing partner of a New Hampshire-based private equity firm was indicted for allegedly fraudulently soliciting over $50 million in investments for purported health and wellness companies, using the money to support his personal image and wife's skincare brand instead of properly paying investors and employees.

  • December 18, 2025

    UAW Leaders Deleted Retaliation Plot Texts, Monitor Finds

    A watchdog overseeing United Auto Workers' kickback-scandal reforms told a Michigan judge Thursday that UAW President Shawn Fain and top officials obstructed his investigation into their plot to oust the secretary-treasurer by deleting more than 100 text messages, including one message comparing their plot's success to "epically [dunking] on another player in basketball."

  • December 18, 2025

    Top Trade Secrets Decisions Of 2025

    The Ninth Circuit clarified the rules of engagement in trade secrets disputes with guidance on when confidential information must be precisely detailed during litigation, and jurors delivered a $200 million verdict against Walmart over product freshness technology. Here are Law360's picks for the biggest trade secrets decisions of 2025.

  • December 18, 2025

    Ex-Connecticut Utility Regulator Fined Amid Records Brawl

    Connecticut's Freedom of Information Commission voted unanimously to fine the former chair of the Public Utilities Regulatory Authority for the state agency's failure to comply with record requests from an Eversource subsidiary that has accused her of using her position illegally.

  • December 18, 2025

    Unions Come Out Against Rail Giants' $85B Merger

    Two Teamsters unions representing a majority of organized workers at Norfolk Southern and Union Pacific came out in opposition this week to the companies' proposed $85 billion merger, arguing the deal would strangle railroads' competitive angle and drive down safety standards.

  • December 18, 2025

    Sprouts Grocery Brass Face Suit Over Rosy Growth Forecast

    The brass of specialty grocery chain Sprouts Farmers Market Inc. face a shareholder derivative suit alleging they hid the risks of faltering consumer spending, and ended up overpaying by $26.5 million on stock buybacks ahead of an October sales growth miss that caused the company's share price to fall.

  • December 18, 2025

    New NJ Rules Combat AI And Housing Discrimination

    The use of artificial intelligence in hiring practices is among the areas targeted by a sweeping new mandate enacted by New Jersey's Division on Civil Rights meant to shore up protections against discrimination.

  • December 18, 2025

    Vegas Sun Wants Justices To Revive Protective Pact

    The Las Vegas Sun wants the U.S. Supreme Court to take up a Ninth Circuit decision that nixed an agreement protecting it from the Las Vegas Review-Journal's alleged plan to drive it out of business, arguing that the old pact with the more conservative paper was valid even without express government approval.

  • December 18, 2025

    NFL's Bears Dangle Ind. Move As Ill. Stadium Plans Stall

    The Chicago Bears will consider locations for a proposed new stadium outside the city, including in Indiana, because Illinois lawmakers have not supported their plan for suburban Arlington Heights, team President Kevin Warren said.

  • December 18, 2025

    Agita Over Piglets At Party Got Pharma Exec Axed, Suit Says

    The U.S. arm of a Danish pharmaceutical company pushed out a director after he expressed concerns about using baby pigs for a photo op at the company's anniversary party knowing the animals would be euthanized after, a new federal lawsuit alleges.

  • December 18, 2025

    LinkedIn Data Access Settlement Rejected In Antitrust Case

    A California federal court refused to approve a settlement requiring LinkedIn to stop conditioning access to its data interface on rivals agreeing not to use the data for a competing professional social network, a deal that included no damages but up to $4 million in attorney fees.

  • December 18, 2025

    Compliance Chiefs' Enforcement Risks Didn't Ease Up In 2025

    The landscape for chief compliance officers' liability might relax a bit in the coming years as experts anticipate the Trump administration will rely less on a "failure to supervise" theory of liability that financial regulators used to target one chief compliance officer this year.

  • December 18, 2025

    Car Dealer Credit Check Co. Sued Over Breach Affecting 5.8M

    A company that handles credit inquiries for car dealerships is facing a proposed class action accusing it of negligence, following a cyberattack on its systems in October that compromised the personal information of more than 5.8 million people.

  • December 18, 2025

    Trump Orders Loosening Of Federal Restrictions On Marijuana

    President Donald Trump on Thursday announced that his administration would instruct federal agencies to loosen restrictions on cannabis via executive order, a historic acknowledgment from the executive branch that the drug has recognized medical uses.

  • December 17, 2025

    JPMorgan Ex-Advisers Sue Over Alleged Race And Sex Bias

    JPMorgan Chase & Co. and its broker-dealer unit are facing claims they discriminated against two Black women who had worked for the companies as financial advisers, giving them unfavorable branch assignments and leave-related client reassignments while later forcing them to take lower-paying remote jobs they eventually had to quit.

  • December 17, 2025

    Meta Blamed For Teens' Instagram 'Sextortion' Suicides

    The parents of a 16-year-old boy from Scotland and a 13-year-old boy from Pennsylvania blame Meta and Instagram for their children dying by suicide after being "sextorted" through the photo sharing platform, alleging in a lawsuit Wednesday that the social media companies know the app connects predators to children.

Expert Analysis

  • AI's Role In Google Antitrust Suit May Reshape Tech Markets

    Author Photo

    The evolution of AI in retail has reshaped the U.S.' antitrust case against Google, which could both benefit small business innovators and consumers, and fundamentally alter future antitrust cases, including the Federal Trade Commission's lawsuit against Amazon, says Graham Dufault at ACT.

  • Series

    The Biz Court Digest: How It Works In Massachusetts

    Author Photo

    Since its founding in 2000, the Massachusetts Business Litigation Session's expertise, procedural flexibility and litigant-friendly case management practices have contributed to the development of a robust body of commercial jurisprudence, say James Donnelly at Mirick O’Connell, Felicia Ellsworth at WilmerHale and Lisa Wood at Foley Hoag.

  • How The SEC May Overhaul Its Order Protection Rule

    Author Photo

    Attorneys at Skadden trace the evolution of the controversial Rule 611 of Regulation National Market System, examine the current debate surrounding its effectiveness, and consider how the U.S. Securities and Exchange Commission's emerging Project Crypto initiative could reshape Regulation NMS for a tokenized, on-chain market environment.

  • Why Appellees Should Write Their Answering Brief First

    Author Photo

    Though counterintuitive, appellees should consider writing their answering briefs before they’ve ever seen their opponent’s opening brief, as this practice confers numerous benefits related to argument structure, time pressures and workflow, says Joshua Sohn at the U.S. Department of Justice.

  • FTC Focus: M&A Approvals A Year After Trump's Election

    Author Photo

    The Federal Trade Commission merger-enforcement regime a year since President Donald Trump's election shows how merger approvals have been expedited by the triaging out of more deals, grants for early termination of the Hart-Scott-Rodino waiting period, and zeroing in on preparing solutions for the biggest problems, say attorneys at Proskauer.

  • AG Watch: DC Faces Congressional Push To End Elected Role

    Author Photo

    Given the current structural tension between D.C.'s local autonomy and congressional plenary power, legal and business entities operating in the district should maintain focus on local enforcement gaps, and monitor the legislative process closely, says Lauren Cooper at Hogan Lovells.

  • Federal Acquisition Rules Get Measured Makeover

    Author Photo

    The Trump administration's promised overhaul of the Federal Acquisition Regulation is not a revolution in rules, but a meaningful recalibration of procurement practice that gives contracting officers more space to think, to tailor and to try, say attorneys at Mayer Brown.

  • 2nd Circ. Peloton Ruling Emphasizes Disclosure Context

    Author Photo

    The Second Circuit’s recent decision to revive shareholders’ suit alleging that Peloton made materially misleading statements makes clear that public companies must continually review risk disclosures to determine if previous hypotheticals have materialized, say attorneys at Baker Botts.

  • Series

    Mindfulness Meditation Makes Me A Better Lawyer

    Author Photo

    Mindful meditation enables me to drop the ego, and in helping me to keep sight of what’s important, permits me to learn from the other side and become a reliable counselor, says Roy Wyman at Bass Berry.

  • Lessons From 7th Circ. Decision Affirming $183M FCA Verdict

    Author Photo

    The Seventh Circuit's decision to uphold a $183 million False Claims Act award against Eli Lilly engages substantively with recurring materiality and scienter questions and provides insights into appellate review of complex trial court judgments, say Ellen London at London & Naor, Li Yu at Bernstein Litowitz and Kimberly Friday at Osborn Maledon.

  • HSR Data Shows Most Deals Exit Antitrust Review Unscathed

    Author Photo

    Merger activity is up, enforcement is down and the vast majority of deals are emerging from U.S. federal antitrust review in one piece, new 2024 fiscal-year Hart-Scott-Rodino data shows, meaning companies should not shy away from deals based on a perception that recent antitrust enforcement has been unusually aggressive, says Amanda Wait at Michael Best.

  • Opinion

    Punitive Damages Awards Should Be Limited To 1st Instance

    Author Photo

    Recent verdicts in different cases against Johnson & Johnson and Monsanto showcase a trend of multiple punitive damages being awarded to different plaintiffs for the same course of conduct by a single defendant, a practice that should be deemed unconstitutional by the U.S. Supreme Court, says Jacob Mihm at Polales Horton.

  • How Calif. High Court Is Rethinking Forum Selection Clauses

    Author Photo

    Two recent cases before the California Supreme Court show that the state is shifting toward greater enforcement of freely negotiated forum selection clauses between sophisticated parties, so litigators need to revisit old assumptions about the breadth of California's public policy exception, says Josh Patashnik at Perkins Coie.

  • AI Litigation Tools Can Enhance Case Assessment, Strategy

    Author Photo

    Civil litigators can use artificial intelligence tools to strengthen case assessment and aid in early strategy development, as long as they address the risks and ethical considerations that accompany these uses, say attorneys at Barnes & Thornburg.

  • Attys Beware: Generative AI Can Also Hallucinate Metadata

    Author Photo

    In addition to the well-known problem of AI-generated hallucinations in legal documents, AI tools can also hallucinate metadata — threatening the integrity of discovery, the reliability of evidence and the ability to definitively identify the provenance of electronic documents, say attorneys at Law & Forensics.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Corporate archive.